APMAP and cervical carcinoma: To verify whether APMAP promoted the migration and EMT of cervical cancer cells through the Wnt/β-catenin pathway, we used the β-catenin agonist SKL2001 to activate β-catenin in the APMAP knockdown cells (Figure 4D).